Allisartan Isoproxil

allisartan isoproxil · Shenzhen Salubris Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Allisartan Isoproxil, covering 2024-06-28 to 2024-07-15. Get the full timeline:

Most recent: Clinical Trial Update: To Assess Allisartan Isoproxil/Sustained-Release Indapamide in Patients With Essential Hypertension Uncontrolled With Allisartan Isoproxil [Phase 3]

See pricing